Press Releases May 14, 2026 07:01 AM

Chicago Atlantic BDC, Inc. Declares $0.34 Cash Dividend for Second Quarter 2026

Chicago Atlantic BDC declares $0.34 quarterly cash dividend for Q2 2026, focusing on cannabis and middle-market direct loans

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
LIEN

Chicago Atlantic BDC, Inc., a specialty finance company focused on lending to privately held middle-market and cannabis companies, announced a $0.34 per share cash dividend for the quarter ending June 30, 2026. The company aims to maximize risk-adjusted returns through its investment strategy and is regulated as a business development company.

Chicago Atlantic BDC, Inc. Declares $0.34 Cash Dividend for Second Quarter 2026
LIEN
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Declared a $0.34 per share cash dividend for Q2 2026 with record date June 26 and payment date July 10, 2026.
  • Invests primarily in direct loans to privately held middle-market companies, especially cannabis sector businesses.
  • Managed by Chicago Atlantic BDC Advisers, focusing on niche and underfollowed sectors, emphasizing the cannabis industry.

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) -- Chicago Atlantic BDC, Inc. (“the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced that the Company’s board of directors has declared a cash dividend of $0.34 per share for the quarter ending June 30, 2026. The following are the key dates for the dividends:

Record DateJune 26, 2026Payment DateJuly 10, 2026  

About Chicago Atlantic BDC, Inc.

The Company is a specialty finance company that has elected to be regulated as a business development company under the Investment Company Act of 1940, as amended, and has elected to be treated as a regulated investment company for U.S. federal income tax purposes. The Company’s investment objective is to maximize risk-adjusted returns on equity for its stockholders by investing primarily in direct loans to privately held middle-market companies, with a primary focus on cannabis companies. The Company is managed by Chicago Atlantic BDC Advisers, LLC, an investment manager focused on the cannabis industry and other niche or underfollowed sectors. For more information, please visit Chicago Atlantic BDC, Inc..

Forward-Looking Statements
Certain information contained herein may constitute “forward-looking statements” that involve substantial risks and uncertainties. Such statements involve known and unknown risks, uncertainties and other factors and undue reliance should not be placed thereon. These forward-looking statements are not historical facts, but rather are based on current expectations, estimates and projections about the Company, its current and prospective portfolio investments, its industry, its beliefs and opinions, and its assumptions. Words such as “anticipates,” “expects,” “intends,” “plans,” “will,” “may,” “continue,” “believes,” “seeks,” “estimates,” “would,” “could,” “should,” “targets,” “projects,” “outlook,” “potential,” “predicts” and variations of these words and similar expressions are intended to identify forward-looking statements. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond the Company’s control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements including, without limitation, the risks, uncertainties and other factors identified in the Company’s filings with the U.S. Securities and Exchange Commission. Investors should not place undue reliance on these forward-looking statements, which apply only as of the date on which the Company makes them. The Company does not undertake any obligation to update or revise any forward-looking statements or any other information contained herein, except as required by applicable law.

Contact:
Tripp Sullivan
Lisa Kampf
SCR Partners, LLC
LIEN@chicagoatlantic.com


Risks

  • Exposure to the cannabis industry entails regulatory, legal, and market uncertainties impacting investment returns.
  • Forward-looking statements involve risks and uncertainties; actual results may differ materially due to factors beyond the company's control.
  • Dependence on privately held middle-market companies can lead to illiquidity and credit risks affecting dividend sustainability.

More from Press Releases

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Upstream Bio Presents New Responder Analyses Demonstrating Clinically Meaningful Improvements in CRSwNP in Significant Majority of Participants Treated with Verekitug in the Phase 2 VIBRANT Trial at EAACI 2026 Jun 14, 2026 Mineralys Therapeutics Presents Late-Breaking Data on Lorundrostat and Heart Failure Risk Biomarkers at The Endocrine Society Annual Meeting (ENDO 2026) Jun 14, 2026 Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting Jun 14, 2026 Legend Biotech Establishes Clinical Proof-of-Concept for LB2501, a Potential First-in-Class In Vivo CD19/CD20 Dual-Targeting CAR-T, in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma Jun 14, 2026